Zobrazeno 1 - 10
of 98
pro vyhledávání: '"M, Millenson"'
Autor:
Alexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion E. Cole, Samuel Litwin, Michael M. Millenson, Tahseen Al-Saleem, Adam D. Cohen, Kerry S. Campbell
Publikováno v:
OncoImmunology, Vol 6, Iss 7 (2017)
A prospective analysis of natural killer (NK) cell phenotype and function was performed on fresh peripheral blood samples from untreated patients with B-cell chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Compared to healthy
Externí odkaz:
https://doaj.org/article/88a0d9c84d12467e99493b7558fedcd3
Autor:
Julia, Judd, Essel, Dulaimi, Tianyu, Li, Michael M, Millenson, Hossein, Borghaei, Mitchell R, Smith, Tahseen, Al-Saleem
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(2)
Tumor-infiltrating immune cells influence diffuse large B-cell lymphoma (DLBCL) outcomes. Relatively little, however, is known about the significance of peripheral blood immune cell numbers on DLBCL behavior.In the present study, 43 patients with new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ee602fa48b55fc42466cc679b314b23
https://pubmed.ncbi.nlm.nih.gov/28027895
https://pubmed.ncbi.nlm.nih.gov/28027895
Autor:
Alex F, Herrera, Allison, Crosby-Thompson, Jonathan W, Friedberg, Gregory A, Abel, Myron S, Czuczman, Leo I, Gordon, Mark S, Kaminski, Michael M, Millenson, Auayporn P, Nademanee, Joyce C, Niland, Scott J, Rodig, Maria A, Rodriguez, Andrew D, Zelenetz, Ann S, LaCasce
Publikováno v:
Cancer. 120(13)
T-cell lymphomas (TCLs) are uncommon in the United States. The accurate diagnosis of TCL is challenging and requires morphologic interpretation, immunophenotyping, and molecular techniques. The authors compared pathologic diagnoses at referring cente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::367fa38a0f8ea5864835519237569105
https://pubmed.ncbi.nlm.nih.gov/24706502
https://pubmed.ncbi.nlm.nih.gov/24706502
Autor:
Michael B. Streiff, Paula L. Bockenstedt, Spero R. Cataland, Carolyn Chesney, Charles Eby, John Fanikos, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Hani Hassoun, Paul Hendrie, Bjorn Holmstrom, Nicole Kuderer, Jason T. Lee, Michael M. Millenson, Anne T. Neff, Thomas L. Ortel, Tanya Siddiqi, Judy L. Smith, Gary C. Yee, Anaadriana Zakarija, Nicole McMillian, Maoko Naganuma
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 11(11)
Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01966eefe06c0033523c3e31e9ae5efb
https://pubmed.ncbi.nlm.nih.gov/24225973
https://pubmed.ncbi.nlm.nih.gov/24225973
Autor:
Lawrence D, Wagman, Melissa F, Baird, Charles L, Bennett, Paula L, Bockenstedt, Spero R, Cataland, John, Fanikos, Patrick F, Fogarty, Samuel Z, Goldhaber, Tejpal S, Grover, William, Haire, Hani, Hassoun, Suzanne, Hutchinson, Mohammad, Jahanzeb, Jason, Lee, Michael L, Linenberger, Michael M, Millenson, Thomas L, Ortel, Riad, Salem, Judy L, Smith, Michael B, Streiff, Suresh, Vedantham
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 6(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c3d7f0562c9c9be7383632f4fc3df03
https://pubmed.ncbi.nlm.nih.gov/18926086
https://pubmed.ncbi.nlm.nih.gov/18926086
Autor:
Lawrence D, Wagman, Melissa F, Baird, Charles L, Bennett, Paula L, Bockenstedt, Spero R, Cataland, John, Fanikos, Patrick F, Fogarty, Samuel Z, Goldhaber, Tejpal S, Grover, William, Haire, Hani, Hassoun, Mohammad, Jahanzeb, Lawrence L, Leung, Michael L, Linenberger, Michael M, Millenson, Thomas L, Ortel, Riad, Salem, Judy L, Smith, Michael B, Streiff
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 4(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::079fe1c8bbdfc2cbe84d9a8e73e38d91
https://pubmed.ncbi.nlm.nih.gov/17020664
https://pubmed.ncbi.nlm.nih.gov/17020664
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma
Autor:
Gloria J, Morris, Michael M, Millenson, Kristin, Padavic-Shaller, Hao, Wang, Andre, Rogatko, James, Clyde, Robert L, Boyd, Gwen, Yeslow, Theresa, Halbherr, Russell J, Schilder, Mitchell R, Smith
Publikováno v:
Haematologica. 89(12)
Low-grade non-Hodgkin's lymphoma (NHL) remains incurable with standard dose chemotherapy. Nucleoside analogs such as fludarabine are effective, but even when used as initial therapy, the median duration of remission ranges from only 16 to 24 months.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7a836937b6788d1010d145242d284ad
https://pubmed.ncbi.nlm.nih.gov/15590399
https://pubmed.ncbi.nlm.nih.gov/15590399
Autor:
F R, Appelbaum, M R, Baer, M H, Carabasi, S E, Coutre, H P, Erba, E, Estey, M J, Glenn, E H, Kraut, P, Maslak, M, Millenson, C B, Miller, H I, Saba, R, Stone, M S, Tallman
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57e445a34686b15090b66ecfcdf9729a
https://pubmed.ncbi.nlm.nih.gov/11195419
https://pubmed.ncbi.nlm.nih.gov/11195419
Autor:
M, Millenson
Publikováno v:
Hospitalshealth networks. 74(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e82f1626af05e6d4f0e9770216b6470f
https://pubmed.ncbi.nlm.nih.gov/11193995
https://pubmed.ncbi.nlm.nih.gov/11193995
Autor:
M, Millenson, D, Young, M, Wood, C, Pryde, C, Kivlahan, J, Dubinsky, W, Breidenbach, R, Kelley, E, Hughes
Publikováno v:
Healthplan. 40(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a5731cd06ea453962ff71c928e50efc
https://pubmed.ncbi.nlm.nih.gov/10538086
https://pubmed.ncbi.nlm.nih.gov/10538086